SEC 13F Intelligence

Equitec Proprietary Markets, LLC / XLRN

Equitec Proprietary Markets, LLC’s Acceleron Pharma Inc Position

Does Equitec Proprietary Markets, LLC own Acceleron Pharma Inc (XLRN)? Not currently — the last reported position was 43.3K shares worth $7M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$7M
Q3 2021
Shares
43.3K
% of Portfolio
+1.38%
Quarters Held
1
position exited

Position History XLRN

Reported value by quarter
Q3 ’21: $7MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202143.3K$7M+1.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Equitec Proprietary Markets, LLC’s full portfolio or all institutional holders of XLRN.